{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:14:02Z","timestamp":1788437642439,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.vhri.2026.101592","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:05:30Z","timestamp":1772139930000},"page":"101592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Healthcare Attributable Costs of Rheumatoid Arthritis in Colombia: A Real-World Study Based on National Contributory Scheme Claims Data"],"prefix":"10.1016","volume":"55","author":[{"given":"Kevin","family":"Maldonado-Ca\u00f1\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Quintana-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vhri.2026.101592_bib1","first-page":"245","article-title":"Prevalencia de la enfermedad reum\u00e1tica en Colombia, seg\u00fan estrategia COPCORD-Asociaci\u00f3n Colombiana de Reumatolog\u00eda. Estudio de prevalencia de enfermedad reum\u00e1tica en poblaci\u00f3n colombiana mayor de 18 a\u00f1os","volume":"25","author":"Londo\u00f1o","year":"2018","journal-title":"Rev Colomb Reumatol"},{"issue":"10","key":"10.1016\/j.vhri.2026.101592_bib2","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"Black","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.vhri.2026.101592_bib3","series-title":"Situaci\u00f3n de la Artritis Reumatoide en Colombia 2021","year":"2022"},{"issue":"10","key":"10.1016\/j.vhri.2026.101592_bib4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.23512","article-title":"Medical care costs associated with rheumatoid arthritis in the US: a systematic literature review and meta-analysis","volume":"70","author":"Hresko","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3111\/13696998.2014.969434","article-title":"Adjusting for comorbidities in cost of illness studies","volume":"18","author":"Rizzo","year":"2015","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.vhri.2026.101592_bib6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014","volume":"37","author":"Hunter","year":"2017","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.vhri.2026.101592_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/annrheumdis-2019-216243","article-title":"Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era","volume":"79","author":"Hsieh","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7705\/biomedica.v29i1.40","article-title":"Costos directos de la artritis reumatoide temprana en el primer a\u00f1o de atenci\u00f3n: simulaci\u00f3n de tres situaciones cl\u00ednicas en un hospital universitario de tercer nivel en Colombia","volume":"29","author":"Mora","year":"2009","journal-title":"Biom\u00e9dica"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib9","first-page":"26","article-title":"Costos directos del tratamiento de pacientes con artritis reumatoide en Medell\u00edn, Colombia","volume":"18","author":"Montoya","year":"2011","journal-title":"Rev Colomb Reumatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib10","first-page":"24","article-title":"Resource utilization and the cost of rheumatoid arthritis in Brazil","volume":"26","author":"Chermont","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41927-025-00459-1","article-title":"Exploring drug utilization patterns, healthcare resource utilization, and epidemiology of rheumatoid arthritis in Colombia: a retrospective claims database study","volume":"9","author":"Fern\u00e1ndez-\u00c1vila","year":"2025","journal-title":"BMC Rheumatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.11606\/s1518-8787.2023057004280","article-title":"Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system","volume":"57","author":"Mega","year":"2023","journal-title":"Rev Saude Publ"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib13","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1186\/s12913-023-10298-w","article-title":"Health and economic impact associated with rheumatoid arthritis discharges: a cost analysis of a two-year cohort in Mexico","volume":"23","author":"Mendoza-Gutierrez","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vhri.2026.101592_bib14","series-title":"Bolet\u00edn de aseguramiento en salud. Bolet\u00edn No 01-Primer","year":"2017"},{"key":"10.1016\/j.vhri.2026.101592_bib15","article-title":"Fragmentation of care and its association with survival and costs for patients with breast cancer in Colombia","volume":"9","author":"Gamboa","year":"2023","journal-title":"JCO Glob Oncol"},{"issue":"8","key":"10.1016\/j.vhri.2026.101592_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290734","article-title":"Teaching hospitals and their influence on survival after valve replacement procedures: a retrospective cohort study using inverse probability of treatment weighting (IPTW)","volume":"18","author":"Maldonado-Ca\u00f1\u00f3n","year":"2023","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.vhri.2026.101592_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269079","article-title":"Prevalence of lung cancer in Colombia and a new diagnostic algorithm using health administrative databases: a real-world evidence study","volume":"18","author":"Amaya-Nieto","year":"2023","journal-title":"PLOS One"},{"issue":"11","key":"10.1016\/j.vhri.2026.101592_bib18","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3390\/ph15111409","article-title":"Acute kidney injury in a cohort of critical illness patients exposed to non-steroidal anti-inflammatory drugs","volume":"15","author":"Oliveros","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s42358-025-00437-8","article-title":"Prevalence, comorbidities, and disease-related complications of rheumatoid arthritis in Colombia: a national cross-sectional study based on administrative claims data","volume":"65","author":"Maldonado-Ca\u00f1\u00f3n","year":"2025","journal-title":"Adv Rheumatol"},{"issue":"9","key":"10.1016\/j.vhri.2026.101592_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/aje\/kwq224","article-title":"Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score","volume":"172","author":"Austin","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.vhri.2026.101592_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3899\/jrheum.180668","article-title":"Comorbidities in patients with rheumatoid arthritis and their association with patient-reported outcomes: results of claims data linked to questionnaire survey","volume":"46","author":"Luque Ramos","year":"2019","journal-title":"J Rheumatol"},{"issue":"25","key":"10.1016\/j.vhri.2026.101592_bib23","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.vhri.2026.101592_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251334","article-title":"Health care costs of rheumatoid arthritis: a longitudinal population study","volume":"16","author":"Tatangelo","year":"2021","journal-title":"PLOS One"},{"key":"10.1016\/j.vhri.2026.101592_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2288-12-78","article-title":"t-tests, non-parametric tests, and large studies\u2014a paradox of statistical practice?","volume":"12","author":"Fagerland","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1016\/j.vhri.2026.101592_bib27","first-page":"328","article-title":"[\u2018R\u2019\u2014project for statistical computing]","volume":"170","author":"Dessau","year":"2008","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.vhri.2026.101592_bib28","series-title":"Stata Statistical Software. Release 17","year":"2021"},{"issue":"10","key":"10.1016\/j.vhri.2026.101592_bib29","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1093\/rheumatology\/keab078","article-title":"Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study","volume":"60","author":"Roodenrijs","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vhri.2026.101592_bib30","article-title":"Incremental healthcare costs of diabetes mellitus in a middle-income country using administrative healthcare data","volume":"43","author":"Castro-Villarreal","year":"2024","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.vhri.2026.101592_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12939-022-01818-x","article-title":"Characterization of the population affiliated to the subsidized health insurance scheme in Colombia: a systematic review and meta-analysis","volume":"22","author":"Mora-Moreo","year":"2023","journal-title":"Int J Equity Health"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:21:56Z","timestamp":1788434516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S2212109926000063"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101592","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare Attributable Costs of Rheumatoid Arthritis in Colombia: A Real-World Study Based on National Contributory Scheme Claims Data","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101592"}}